Pro Health Tips
Thursday, 20 May 2021
Dupilumab Decreased Asthma Episodes in Children Aged 6-11
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children aged 6-11 years.
from Medindia Health News https://ift.tt/3vkuRLn
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children aged 6-11 years.
No comments:
Post a Comment